Letter From the Editor: I Wish I Knew . . .

On April 6, 2023, AbbVie announced its intent to voluntarily withdraw its accelerated approval for ibrutinib in mantle cell lymphoma and marginal zone lymphoma in the […]

Letter From the Editor: How Do We Celebrate—and Survive—Increasing Survival?

As I approach my 25th year in oncology practice, I think back to when I started and the remarkable expansion since then of treatment options for […]

Letter From the Editor: Informed Consent?

This month, I continue my series of letters on thought-provoking clinical scenarios that have arisen during my time on the inpatient lymphoma service. The subject of […]

Letter From the Editor: Clinical Research Under Siege

Over the last three years, many of us who work in clinical research have felt an increased strain on our fragile infrastructures. I am tempted to […]

Letter From the Editor: Too Much?

As previously mentioned, I want to continue sharing some of the thought-provoking and relevant clinical scenarios that arise during my time on the inpatient lymphoma service. […]

Letter From the Editor: How We Win Against Cancer

Doctors frequently rely on metaphors to communicate complicated and technical biological concepts to patients. For cancer treatment, the metaphor of a battle or war has been […]

Letter From the Editor: The Third Tier

I recently completed another two-week rotation on the lymphoma service at NewYork-Presbyterian Hospital/Weill Cornell Medicine, which always provides me with much food for thought. Many topics of […]

Letter From the Editor: Computational Faith

I have always had great reverence for our colleagues in biostatistics. Whether my reverence derives from the limitations of my own statistical training or from the […]

Letter From the Editor: There Has to Be a God . . .

Evolution is described as the ultimate and inevitable result of random mutations occurring over successive generations, leading to functional improvements in organisms that provide a survival […]

“Degriefing”

In this issue you will find a thoughtful and sobering essay by Drs Anthony Galanos and Matthew Labriola, my colleagues at Duke, called “How We Manage […]

I Think the FDA Got It Wrong …

We have experienced a string of great successes in clinical therapeutics for CLL over the past several years, both in the number of novel therapies approved […]

Letter From the Editor: Divide and Conquer, Cancer

Returning from the 2022 ASCO Annual Meeting in June, I felt a sense of renewal. Although attendance was clearly down from years past, 30,000 people registered […]

Letter From the Editor: Debate, Argument, or Discussion?

At a recent debate on the treatment of CLL, I was going head-to-head with a colleague regarding whether BTK inhibitors or venetoclax should be first-line therapy. […]

Letter From the Editor: Back Together: Rebuilding Our Professional Culture

If you are like me, the weight of the pandemic has become so chronic that you have forgotten what the old way of life felt like. […]

COVID-19 Vaccine Development

My letter in the February 2022 issue of Clinical Advances in Hematology & Oncology called for Dr Anthony Fauci to address inherent deficiencies in our national […]

Letter From the Editor: Read My Lips

It will be close to springtime when this editorial is published, although I am writing it on a cold and rainy afternoon in February. It is […]

Letter From the Editor: An Open Letter to Dr Fauci

Dear Dr Fauci, I would like to commend you on the phenomenal job you have been doing as chief medical advisor to the President during the […]

Letter From the Editor: Nursing Help Wanted

Shortfalls in staffing are hurting many sectors of our economy, but health care seems to be taking a particularly hard hit. Nurses have been in short […]

To Boost or Not to Boost?

To boost or not to boost, that is the question—or rather, one of many questions regarding COVID-19 vaccination in the United States. Do we mandate vaccination […]

Letter From the Editor: Addressing the Racial Gap in Health Care

I was disheartened when I read the article “The Black Mortality Gap, and a Document Written in 1910” in the August 30 edition of The New […]